Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 4
1999 1
2001 2
2002 1
2004 2
2005 1
2006 2
2007 6
2008 6
2009 1
2010 6
2011 4
2012 7
2013 10
2014 13
2015 11
2016 11
2017 8
2018 4
2019 4
2020 5
2022 3
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 25180626

102 results
Results by year
Filters applied: . Clear all
Page 1
Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.
Gopal T, Kumar N, Perriotte-Olson C, Casey CA, Donohue TM Jr, Harris EN, Talmon G, Kabanov AV, Saraswathi V. Gopal T, et al. Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G428-G438. doi: 10.1152/ajpgi.00217.2019. Epub 2020 Jan 13. Am J Physiol Gastrointest Liver Physiol. 2020. PMID: 31928222 Free PMC article.
Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model.
Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, Ibdah JA. Rector RS, et al. J Hepatol. 2010 May;52(5):727-36. doi: 10.1016/j.jhep.2009.11.030. Epub 2010 Mar 4. J Hepatol. 2010. PMID: 20347174 Free PMC article.
102 results